SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-17-030438
Filing Date
2017-08-08
Accepted
2017-08-08 07:31:13
Documents
3
Period of Report
2017-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm 8-K 18942
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 134236
3 image00002.jpg GRAPHIC 2633
  Complete submission text file 0001140361-17-030438.txt   158035
Mailing Address 2855 GAZELLE CT CARLSBAD CA 92010
Business Address 55 CAMBRIDGE PARKWAY SUITE 100 CAMBRIDGE MA 02142 760-603-2732
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 171013244
SIC: 2834 Pharmaceutical Preparations